The Tobacco Products Scientific Advisory Committee; Notice of Meeting; Amendment of Notice, 49879-49880 [2024-12784]
Download as PDF
<![CDATA[
49879
Federal Register / Vol. 89, No. 114 / Wednesday, June 12, 2024 / Notices
cumulative counts across the grant
period, negating the need for a separate
final report.
Current grant recipients will be able
to choose between using the current
forms and the revised forms through the
completion of their current project. New
grant recipients will be required to use
the revised forms.
Respondents: There will be three
types of respondents to the proposed
instruments. First, the direct
beneficiaries, the clients receiving
supportive services, will participate in
the service receipt questionnaire, selfsufficiency matrix, and focus groups,
and they will also provide information
about their characteristics, needs, and
outcomes for the grant recipients’ semiannual reporting. Second, the program
directors and social services staff will
respond to interview instruments
tailored to their roles. Grant recipients
will also be asked to complete quarterly
PPRs and semi-annual reports to
describe their service delivery activities,
and outcomes.
Instrument
Interviews with program directors ............................................................
Interviews with caseworkers ....................................................................
Focus groups with residents ....................................................................
Self-sufficiency matrix ..............................................................................
Service receipt questionnaire ..................................................................
Semi-Annual Report Mandatory—original form .......................................
Semi-Annual Report Mandatory—revised form .......................................
Semi-Annual Report Optional—original form ..........................................
Semi-Annual Report Optional—revised form ..........................................
PPR Narrative Report ..............................................................................
Estimated Total Annual Burden
Hours: 1,947.
Comments: The Department
specifically requests comments on (a)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Authority: Section 1110, Social
Security Act, 42 U.S.C. 1310.
Mary C. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2024–12875 Filed 6–11–24; 8:45 am]
ddrumheller on DSK120RN23PROD with NOTICES1
BILLING CODE 4184–24–P
VerDate Sep<11>2014
17:43 Jun 11, 2024
Jkt 262001
Total
number of
responses per
respondent
18
36
50
1,000
1,000
9
9
6
6
18
1
1
1
3
3
4
3
4
3
6
Administration for Community Living
Notice of Federal Review of the
Alabama Protection and Advocacy
System (P&A)
Administration for Community
Living, HHS.
ACTION: Notice.
AGENCY:
Representatives of the
Administration on Disabilities (AoD),
Administration for Community Living
(ACL), will be conducting a federal
review of the Alabama Protection and
Advocacy System (P&A), Alabama
Disability Advocacy Program (ADAP) on
July 22–26, 2024. AoD is soliciting
comments from interested parties on
your experiences with the program, and
strategies employed by the P&A ADAP
in meeting the needs of individuals with
developmental disabilities and their
families in Alabama.
DATES: Comments from interested
parties must be submitted electronically
by 11:59 p.m. (ET) by July 31, 2024 in
order to be included in the final report.
ADDRESSES: You are encouraged to share
your experiences with Selvin Garcia,
Administration on Disabilities,
Administration for Community Living
by email at Selvin.Garcia@acl.hhs.gov;
by telephone at 202–795–7567; or by
mail to Selvin Garcia Administration on
Disabilities, Administration for
SUMMARY:
Frm 00056
Fmt 4703
Burden estimates show the total
number of responses per respondent
over the next 3 years. The current grant
recipients (9 total) will be able to choose
between using the current forms and the
revised forms through the completion of
their current project. New grant
recipients (9 new recipients estimated)
will be required to use the revised
forms.
Total
number of
respondents
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Annual Burden Estimates
Sfmt 4703
Average
burden hours
per response
1.5
1
1.5
1.5
.25
2
3
2
2
2
Total
burden
hours
Annual
burden
hours
27
36
75
4,500
750
72
81
48
36
216
9
12
25
1,500
250
24
27
16
12
72
Community Living, 330 C Street SW, 1st
Floor, Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT:
Selvin Garcia, Administration on
Disabilities, Administration for
Community Living, at Selvin.Garcia@
acl.hhs.gov or 202–795–7567.
Dated: June 6, 2024.
Alison Barkoff,
Principal Deputy Administrator for the
Administration for Community Living,
performing the delegable duties of the
Administrator and the Assistant Secretary for
Aging.
[FR Doc. 2024–12824 Filed 6–11–24; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2024–N–0008]
The Tobacco Products Scientific
Advisory Committee; Notice of
Meeting; Amendment of Notice
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency) is
announcing an amendment of the notice
of meeting of the Tobacco Products
Scientific Advisory Committee
(TPSAC). This meeting was announced
SUMMARY:
E:\FR\FM\12JNN1.SGM
12JNN1
49880
Federal Register / Vol. 89, No. 114 / Wednesday, June 12, 2024 / Notices
in the Federal Register of May 6, 2024.
The amendment is being made to reflect
a change in the ADDRESSES portion of
the document and to reflect a change in
the Procedure portion. There are no
other changes.
FOR FURTHER INFORMATION CONTACT:
Serina Hunter-Thomas, Office of
Science, Center for Tobacco Products,
Food and Drug Administration,
Document Control Center, Bldg. 71, Rm.
G335, 10903 New Hampshire Ave.,
Silver Spring, MD 20993–0002, 1–877–
287–1373, email: TPSAC@fda.hhs.gov,
or FDA Advisory Committee
Information Line, 1–800–741–8138
(301–443–0572 in the Washington, DC
area). Please call the Information Line
for up-to-date information on this
meeting.
In the
Federal Register of May 6, 2024 (89 FR
37231), FDA announced that a meeting
of the Tobacco Products Scientific
Advisory Committee would be held on
June 26, 2024, from 9 a.m. to 4:30 p.m.
EST. On page 37232, in the first column,
the last paragraph of the ADDRESSES
portion of the document is changed to
read as follows:
For those unable to attend in person,
the meeting will also be webcast and
will be available at the following link:
https://fda.zoomgov.com/j/
1604157441?pwd=YkVzZ28vNHQr
VXh3ZlhrTmlHaFVzZz09; Passcode:
H*a5nF.
In addition, on page 37232 in the
middle column under Procedure, the
oral presentations or open public
hearing time is now scheduled to start
at 11:30 a.m. and end at 12:30 p.m. EST
on June 26, 2024.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. 1001 et seq.) and 21 CFR part 14,
relating to the advisory committees.
SUPPLEMENTARY INFORMATION:
Dated: June 6, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024–12784 Filed 6–11–24; 8:45 am]
ddrumheller on DSK120RN23PROD with NOTICES1
BILLING CODE 4164–01–P
VerDate Sep<11>2014
17:43 Jun 11, 2024
Jkt 262001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2024–N–2583]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Human Drug
Compounding, Repackaging, and
Related Activities Regarding Sections
503A and 503B of the Federal Food,
Drug, and Cosmetic Act
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA, Agency, or we) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on information
collection associated with Agency
guidance documents pertaining to
pharmacies, outsourcing facilities, and
other entities with regard to human drug
compounding, repackaging, and related
activities.
DATES: Either electronic or written
comments on the collection of
information must be submitted by
August 12, 2024.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. The https://
www.regulations.gov electronic filing
system will accept comments until
11:59 p.m. Eastern Time at the end of
August 12, 2024. Comments received by
mail/hand delivery/courier (for written/
paper submissions) will be considered
timely if they are received on or before
that date.
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2024–N–2583 for ‘‘Human Drug
Compounding, Repackaging, and
Related Activities Regarding Sections
503A and 503B of the Federal Food,
Drug, and Cosmetic Act.’’ Received
comments, those filed in a timely
manner (see ADDRESSES), will be placed
in the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
E:\FR\FM\12JNN1.SGM
12JNN1
]]>Agencies
[Federal Register Volume 89, Number 114 (Wednesday, June 12, 2024)]
[Notices]
[Pages 49879-49880]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-12784]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2024-N-0008]
The Tobacco Products Scientific Advisory Committee; Notice of
Meeting; Amendment of Notice
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
an amendment of the notice of meeting of the Tobacco Products
Scientific Advisory Committee (TPSAC). This meeting was announced
[[Page 49880]]
in the Federal Register of May 6, 2024. The amendment is being made to
reflect a change in the ADDRESSES portion of the document and to
reflect a change in the Procedure portion. There are no other changes.
FOR FURTHER INFORMATION CONTACT: Serina Hunter-Thomas, Office of
Science, Center for Tobacco Products, Food and Drug Administration,
Document Control Center, Bldg. 71, Rm. G335, 10903 New Hampshire Ave.,
Silver Spring, MD 20993-0002, 1-877-287-1373, email: [email protected],
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area). Please call the Information Line for
up-to-date information on this meeting.
SUPPLEMENTARY INFORMATION: In the Federal Register of May 6, 2024 (89
FR 37231), FDA announced that a meeting of the Tobacco Products
Scientific Advisory Committee would be held on June 26, 2024, from 9
a.m. to 4:30 p.m. EST. On page 37232, in the first column, the last
paragraph of the ADDRESSES portion of the document is changed to read
as follows:
For those unable to attend in person, the meeting will also be
webcast and will be available at the following link: https://fda.zoomgov.com/j/1604157441?pwd=YkVzZ28vNHQrVXh3ZlhrTmlHaFVzZz09;
Passcode: H*a5nF.
In addition, on page 37232 in the middle column under Procedure,
the oral presentations or open public hearing time is now scheduled to
start at 11:30 a.m. and end at 12:30 p.m. EST on June 26, 2024.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. 1001 et seq.) and 21 CFR part 14, relating to the advisory
committees.
Dated: June 6, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024-12784 Filed 6-11-24; 8:45 am]
BILLING CODE 4164-01-P
